{"EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$132 to $135"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$130"}, {"Date": "2022-02-02", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$121 to $126"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$125 to $121"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$132 to $120"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$134 to $126"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$130 to $122"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$142 to $138"}, {"Date": "2021-12-17", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$114 to $140"}], "Score": 1.56, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 9, "Period": "180 days", "Analists": ["Bernstein", "JP Morgan", "BofA Securities", "Stifel", "Evercore ISI", "Citigroup", "UBS", "Raymond James"], "Price_Target": 128.67}, "EXPD": {"Ticker": "EXPD", "Company": "Expeditors", "Sector": "Industrials", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Initiated", "Organization": "The Benchmark Company", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$132 to $112"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["The Benchmark Company", "Cowen"], "Price_Target": 55.0}, "HST": {"Ticker": "HST", "Company": "Host Hotels & Resorts", "Sector": "Real Estate", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$21"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Raymond James"], "Price_Target": 21.0}, "JNJ": {"Ticker": "JNJ", "Company": "Johnson & Johnson", "Sector": "Health Care", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$180 to $183"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$185"}, {"Date": "2021-12-17", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$161"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Goldman", "Bernstein", "BofA Securities"], "Price_Target": 176.33}, "MU": {"Ticker": "MU", "Company": "Micron Technology", "Sector": "Information Technology", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$94"}, {"Date": "2022-02-14", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Neutral to Outperform", "Target_Change": "$100 to $120"}, {"Date": "2022-01-10", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$100 to $118"}, {"Date": "2022-01-10", "Rating": "Initiated", "Organization": "New Street", "Rating_Change": "Buy", "Target_Change": "$135"}, {"Date": "2021-12-21", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2021-12-21", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$76 to $100"}], "Score": 1.83, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Analists": ["Bernstein", "Summit Insights", "Wedbush", "BofA Securities", "New Street"], "Price_Target": 93.5}, "SBUX": {"Ticker": "SBUX", "Company": "Starbucks", "Sector": "Consumer Discretionary", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$101"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$110 to $106"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$115 to $105"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$135 to $125"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$122 to $108"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$108 to $100"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$115 to $107"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "MKM Partners", "Rating_Change": "Buy", "Target_Change": "$130 to $123"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$112 to $101"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$115 to $107"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": "$120 to $115"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$132 to $122"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$125 to $115"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$129 to $120"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$135 to $125"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$136 to $125"}, {"Date": "2022-02-02", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$112 to $106"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$142 to $130"}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$124 to $122"}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2021-12-17", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$126 to $116"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 21, "Period": "180 days", "Analists": ["Robert W. Baird", "Wedbush", "Citigroup", "Stephens", "Morgan Stanley", "JP Morgan", "Jefferies", "Oppenheimer", "Evercore ISI", "MKM Partners", "Guggenheim", "Barclays", "RBC Capital Mkts", "Credit Suisse", "Piper Sandler", "UBS", "BMO Capital Markets", "Cowen", "Goldman"], "Price_Target": 107.52}, "SYK": {"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2022-03-16", "Rating": [{"Date": "2022-03-16", "Rating": "Upgrade", "Organization": "Bernstein", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$288 to $295"}, {"Date": "2022-03-15", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$284"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$300"}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$305"}, {"Date": "2022-01-04", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$250 to $315"}], "Score": 1.4, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Analists": ["Morgan Stanley", "Bernstein", "Evercore ISI", "Piper Sandler", "BofA Securities"], "Price_Target": 299.8}}